Clinical–Alimentary TractSerious lower gastrointestinal clinical events with nonselective NSAID or coxib use☆
References (0)
Cited by (336)
Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain
2023, Pharmacology and TherapeuticsEthosuximide improves chronic pain-induced anxiety- and depression-like behaviors
2019, European NeuropsychopharmacologyPoints to consider in the management of old rheumatologic patients
2019, Revue du Rhumatisme MonographiesLower Gastrointestinal Bleeding
2019, Clinical Gastrointestinal EndoscopyAre NSAIDs Double Trouble? <sup>∗</sup>
2018, Journal of the American College of Cardiology
- ☆
Supported by Merck & Co., Whitehouse Station, New Jersey. Dr. Laine received research support from Merck, and is a consultant for Merck, Pharmacia, Novartis, and Pfizer. Dr. Hawkey has received research funding from AstraZeneca, Alizyme, Boehringer Ingelheim, GlaxoSmithKline, Merck, NicOx, Novartis, and Pfizer. Dr. Schnitzer is a consultant for AstraZeneca, GlaxoSmithKline, McNeil Consumer, Merck, and Novartis, and has received research support from AstraZeneca, Merck, and Novartis. Dr. Bombardier is a consultant for Merck Research Laboratories, Schering Canada, and Wyeth Ayerst Research, has received research grants from Abbott Laboratories (formerly Knoll Pharmaceutical Company), Aventis Pharmaceuticals, and Merck Research Laboratories, and is a member of the Advisory Board for Abbot Laboratories, Bristol-Myers Squibb Company, and Merck Frosst Canada.